Search research articles
Contact Us
Filters
Showing results (631-640 of 721) with videos related to
Page
of 73
Sort By:
Journal of Clinical Medicine
|
May 2, 2020
Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength Evaluation
Ariane Steindl, Johannes Leitner, Matthias Schwarz, et al.
The American Journal of Cardiology
|
August 8, 2009
Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation
Mihael Potocki, Johannes Mair, Michael Weber, et al.
Cancers
|
January 11, 2024
Validation of Inflammatory Prognostic Biomarkers in Pleural Mesothelioma
Stephanie Iser, Sarah Hintermair, Alexander Varga, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
March 5, 2008
Treatment of in-stent restenosis with sirolimus-eluting-stents: results from the prospective German Cypher stent registry
Helge Möllmann, Albrecht Elsässer, Holger Nef, et al.
European Radiology
|
January 12, 2015
Use of diagnostic dynamic contrast-enhanced (DCE)-MRI for targeting of soft tissue tumour biopsies at 3T: preliminary results
Iris-Melanie Noebauer-Huhmann, Gabriele Amann, Martin Krssak, et al.
Neuro-Oncology
|
October 11, 2017
Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas
Nina Poetsch, Adelheid Woehrer, Johanna Gesperger, et al.
Theranostics
|
January 4, 2021
CXCR4 PET imaging of mantle cell lymphoma using [<sup>68</sup>Ga]Pentixafor: comparison with [<sup>18</sup>F]FDG-PET
Marius E Mayerhoefer, Markus Raderer, Wolfgang Lamm, et al.
EMBO Reports
|
June 12, 2026
SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cells
Saskia Kolb, Leonie Diekmann, Elizabeth E Lochert, et al.
The American Journal of Medicine
|
July 2, 2013
Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients
Linong Ji, Dayi Hu, Changyu Pan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 27, 2018
Ultra-early response assessment in lymphoma treatment: [<sup>18</sup>F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment
Marius E Mayerhoefer, Markus Raderer, Ulrich Jaeger, et al.
Page
of 73
Search research articles
Search
Showing results (631-640 of 721) with videos related to
Sort By:
Page
of 73
Journal of Clinical Medicine
|
May 2, 2020
Sarcopenia in Neurological Patients: Standard Values for Temporal Muscle Thickness and Muscle Strength Evaluation
Ariane Steindl, Johannes Leitner, Matthias Schwarz, et al.
The American Journal of Cardiology
|
August 8, 2009
Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation
Mihael Potocki, Johannes Mair, Michael Weber, et al.
Cancers
|
January 11, 2024
Validation of Inflammatory Prognostic Biomarkers in Pleural Mesothelioma
Stephanie Iser, Sarah Hintermair, Alexander Varga, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
March 5, 2008
Treatment of in-stent restenosis with sirolimus-eluting-stents: results from the prospective German Cypher stent registry
Helge Möllmann, Albrecht Elsässer, Holger Nef, et al.
European Radiology
|
January 12, 2015
Use of diagnostic dynamic contrast-enhanced (DCE)-MRI for targeting of soft tissue tumour biopsies at 3T: preliminary results
Iris-Melanie Noebauer-Huhmann, Gabriele Amann, Martin Krssak, et al.
Neuro-Oncology
|
October 11, 2017
Visual and semiquantitative 11C-methionine PET: an independent prognostic factor for survival of newly diagnosed and treatment-naïve gliomas
Nina Poetsch, Adelheid Woehrer, Johanna Gesperger, et al.
Theranostics
|
January 4, 2021
CXCR4 PET imaging of mantle cell lymphoma using [<sup>68</sup>Ga]Pentixafor: comparison with [<sup>18</sup>F]FDG-PET
Marius E Mayerhoefer, Markus Raderer, Wolfgang Lamm, et al.
EMBO Reports
|
June 12, 2026
SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cells
Saskia Kolb, Leonie Diekmann, Elizabeth E Lochert, et al.
The American Journal of Medicine
|
July 2, 2013
Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients
Linong Ji, Dayi Hu, Changyu Pan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 27, 2018
Ultra-early response assessment in lymphoma treatment: [<sup>18</sup>F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment
Marius E Mayerhoefer, Markus Raderer, Ulrich Jaeger, et al.
Page
of 73